Trendlines Group Ltd. engages in the investment and development of medical and agricultural technology companies. The company invests principally through four business units: two Israeli government-franchised incubators, Trendlines Medical and Trendlines Agtech, a Singapore incubator, Trendlines Medical Singapore, and an in-house innovation center, Trendlines Labs. The Group’ s portfolio include more than 50 companies engaged with medical and agricultural technologies and products. The Group is involved in all aspects of its portfolio companies from technology development to business building. The Group in partnerships with entrepreneurs, investors, strategic players, inventors, and governments aims to improve the human condition.
最新の財務諸表(Form-10K)によると、The Trendlines Group Ltd.の総資産は$85で、純利益は$1です。
TRNGFの主要な財務比率は何ですか?
The Trendlines Group Ltd.の流動比率は12.14、純利益率は0、1株当たり売上高は$0です。
The Trendlines Group Ltd.の収益はセグメントまたは地域別にどのように分けられていますか?
The Trendlines Group Ltd. の最大収益セグメントは Innovative Agrifood Tech and Medical Device で、最新の利益発表における収益は -661,522 です。地域別に見ると、Israel が The Trendlines Group Ltd. の主要市場であり、収益は -661,522 です。
The Trendlines Group Ltd.は収益を上げていますか?
はい、最新の財務諸表によると、The Trendlines Group Ltd.の純利益は$1です。